How Acyclovir Can Harm Kidneys
Acyclovir, an antiviral used for herpes infections, is excreted primarily by the kidneys unchanged. High doses or rapid IV infusion cause it to precipitate in renal tubules, leading to acute kidney injury (AKI). This nephrotoxicity occurs in 5-12% of hospitalized patients on IV acyclovir, often within days of starting treatment.[1][2]
Common Kidney Side Effects
- Crystal-induced nephropathy: Acyclovir crystals form in urine at high concentrations (>50 mg/dL), obstructing tubules and causing oliguria or rising creatinine.
- Elevated creatinine: Up to 28% of patients show transient increases; severe cases progress to dialysis-requiring AKI.
- Risk factors: Dehydration, preexisting kidney disease, concurrent nephrotoxins (e.g., NSAIDs), or doses >10 mg/kg IV every 8 hours amplify damage.[3]
Why It Happens: Mechanism Breakdown
Acyclovir has low solubility in acidic urine (pH <7). IV administration overwhelms glomerular filtration, saturating tubules. Precipitation triggers inflammation and vasoconstriction, reducing glomerular filtration rate (GFR). Oral forms pose lower risk due to slower absorption.[1][4]
How to Prevent Kidney Damage
- Hydrate aggressively: 2-3 L/day fluids pre- and during IV therapy to dilute urine.
- Slow infusion: Over 1-2 hours, not bolus.
- Monitor: Check serum creatinine, BUN, and urine output daily; adjust dose by CrCl (e.g., halve for CrCl 25-50 mL/min).
- Alkalinize urine: Target pH >7 with sodium bicarbonate if crystals appear on microscopy.[2][5]
What Happens If Kidneys Are Already Weak?
Patients with baseline CrCl <10 mL/min face 50% higher AKI risk; avoid IV use if possible, switch to oral valacyclovir (better tolerated). Dialysis clears acyclovir efficiently (half-life drops to 2 hours), aiding recovery in severe cases—most regain function within weeks.[3][6]
Recovery and Long-Term Outlook
AKI is usually reversible if caught early; 80-90% recover fully within 1-2 weeks post-discontinuation. Persistent damage is rare but seen in elderly or those with comorbidities. No evidence of chronic kidney disease from short courses.[4]
[1]: Lexicomp: Acyclovir Monograph
[2]: NEJM: Acyclovir Nephrotoxicity
[3]: AJKD: Antiviral Nephrotoxicity Review
[4]: UpToDate: Acyclovir Dosing and Toxicity
[5]: FDA Label: Zovirax (Acyclovir)
[6]: Clinical Infectious Diseases: Acyclovir AKI Management